Phase 1 study of the Aurora kinase A inhibitor alisertib (MLN8237) combined with the histone deacetylase inhibitor vorinostat in lymphoid malignancies
Leukemia & Lymphoma | October 16, 2019 | Volume: 61 | Issue: 2 | Pages: 309-317
10.1080/10428194.2019.1672052
| PMID 31617432